Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrasound Microbubble Destruction and Perfusion Quantification for Improving Radioembolization Therapy of Hepatocellular Carcinoma

NCT03199274 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03199274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03199274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrasound Microbubble Destruction and Perfusion Quantification for Improving Radioembolization Therapy of Hepatocellular Carcinoma
Lead sponsor
Thomas Jefferson University
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2017
Completion date
January 23, 2025
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma